The Evolution of Woodmont Investment Counsel's Portfolio: Q3 2022 vs. Q4 2022
Ava Hoppe | 27 April, 2023
Woodmont Investment Counsel LLC recently released their 13F filings for Q3 and Q4 of 2022. As investment advisors, their goal is to create a profitable portfolio for their clients, and the 13F filings document the firm’s stock holdings at the end of each quarter. As such, we will explore some of the significant changes in Woodmont's portfolio over the last two quarters.
In the third quarter of 2022, Woodmont's portfolio holdings spanned across various sectors, with the financial services sector accounting for the highest percentage of their portfolio. In contrast, the consumer discretionary sector represented the smallest percentage of their holdings. In Q3, Woodmont Investment Counsel LLC held over $417 million in equity assets and reported a total of 53 securities, with their top five holdings representing approximately 37.5% of the portfolio holdings.
Fast forward to Q4 2022, Woodmont Investment Counsel LLC’s total equity assets grew to $492 million, representing an increase of 17.9% compared to the previous quarter. Furthermore, their portfolio holdings witnessed a significant change as several new stocks made their way into the portfolio, while some others exited. In Q4 2022, consumer discretionary replaced the healthcare sector as the smallest percentage of their holdings.
One notable change in their portfolio was the increase in their holdings in Vanguard Index Funds. Specifically, Vanguard Index Funds' VTV, VUG, VO, VTI, and VB increased from Q3 2022 to Q4 2022 by 23.3%, 9.3%, 15.4%, 7.9%, and 20.2%, respectively. This represents an overall increase in Vanguard Index Funds' shareholding of 13.8% from Q3 2022 to Q4 2022.
Apple Inc's shares in Woodmont's portfolio, however, decreased by 4.8% in Q4 2022. Similarly, Chevron Corp New's shares in Woodmont's portfolio reduced by 23.6% from 89,787 shares to 88,864 shares. Merck & Co Inc's shares also decreased by 27.2% from 163,356 to 161,317. Conversely, HCA Healthcare Inc's shares increased by 31% from 56,300 to 56,487 shares.
One other notable change in Woodmont's portfolio was their increased holding in JPMorgan Chase & Co, whose shares increased by 29%, from 77,314 to 77,721 in Q4 2022. The firm also shifted their position in Brookfield Infrastr Partners' BIP, whose shares decreased by 11.8% in Q4 2022 compared to the previous quarter.
Conclusion
In conclusion, the Q3 2022 vs. Q4 2022 13F filing for Woodmont Investment Counsel LLC highlighted some significant changes in the company's stock holdings. The firm added new stocks to their portfolio while reducing their holdings in some others. While the Vanguard Index Funds holdings increased significantly, stocks like Apple Inc, Chevron Corp New, and Merck & Co Inc witnessed a reduction in their shareholding. Overall, the Q3 2022 vs. Q4 2022 13F filings indicate that Woodmont Investment Counsel LLC is in the process of actively repositioning their investment portfolio to create the most profitable outcome for their clients.
Other Posts
- Cetera Advisors LLC Q3 2022 vs. Q4 2022 13F Holdings: A Detailed Analysis of Top Companies
- Argent Capital's Q3 vs. Q4 2022 Holdings: A Look at Top Stocks and Changes
- Shenkman Capital Management Inc Q3 2022 vs. Q4 2022 13F Holdings Comparison
- Navigating the Shifting Sands: How Carlson Capital Management Adjusted Its Portfolio in Early 2024
- Greenwoods Asset Management Ltd Q3 2020 vs Q4 2020: 13F Holdings Comparison
- Strategic Shifts Unveiled: Beacon Capital's Q4 2023 to Q1 2024 Investment Decisions
- Boltwood Capital Management's Q4 2022 vs. Q1 2023: A Look at 13F Holdings Comparison
- Manatt Expands National Advisor Team With Health Care Executive in New York
- Analyzing Alexandria Capital's Q2 and Q3 2021 13F Holdings: Understanding Changes in Top Investments
- TruArc Partners Invests in Watchtower Security